BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38251461)

  • 1. Identifying actionable druggable targets for breast cancer: Mendelian randomization and population-based analyses.
    Zhang N; Li Y; Sundquist J; Sundquist K; Ji J
    EBioMedicine; 2023 Dec; 98():104859. PubMed ID: 38251461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial related genome-wide Mendelian randomization identifies putatively causal genes for multiple cancer types.
    Li Y; Sundquist K; Zhang N; Wang X; Sundquist J; Memon AA
    EBioMedicine; 2023 Feb; 88():104432. PubMed ID: 36634566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mendelian randomization analysis identifies druggable genes and drugs repurposing for chronic obstructive pulmonary disease.
    Wang Z; Li S; Cai G; Gao Y; Yang H; Li Y; Liang J; Zhang S; Hu J; Zheng J
    Front Cell Infect Microbiol; 2024; 14():1386506. PubMed ID: 38660492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for lung cancer.
    Song W; Li Y; Yao Y; Sun S; Guan X; Wang B
    BMC Cancer; 2024 Jun; 24(1):680. PubMed ID: 38834983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mendelian Randomization Using the Druggable Genome Reveals Genetically Supported Drug Targets for Psychiatric Disorders.
    Li X; Shen A; Zhao Y; Xia J
    Schizophr Bull; 2023 Sep; 49(5):1305-1315. PubMed ID: 37418754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: evidence from druggable genome Mendelian randomization and pharmacological verification in vitro.
    Duan QQ; Wang H; Su WM; Gu XJ; Shen XF; Jiang Z; Ren YL; Cao B; Li GB; Wang Y; Chen YP
    BMC Med; 2024 Mar; 22(1):96. PubMed ID: 38443977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying potential drug targets for idiopathic pulmonary fibrosis: a mendelian randomization study based on the druggable genes.
    Liu Z; Peng Z; Lin H; Zhou K; Liang L; Cao J; Huang Z; Mei J
    Respir Res; 2024 May; 25(1):217. PubMed ID: 38783236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma.
    Zhang L; Xiong Y; Zhang J; Feng Y; Xu A
    J Transl Med; 2024 Apr; 22(1):330. PubMed ID: 38576019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19.
    Gaziano L; Giambartolomei C; Pereira AC; Gaulton A; Posner DC; Swanson SA; Ho YL; Iyengar SK; Kosik NM; Vujkovic M; Gagnon DR; Bento AP; Barrio-Hernandez I; Rönnblom L; Hagberg N; Lundtoft C; Langenberg C; Pietzner M; Valentine D; Gustincich S; Tartaglia GG; Allara E; Surendran P; Burgess S; Zhao JH; Peters JE; Prins BP; Angelantonio ED; Devineni P; Shi Y; Lynch KE; DuVall SL; Garcon H; Thomann LO; Zhou JJ; Gorman BR; Huffman JE; O'Donnell CJ; Tsao PS; Beckham JC; Pyarajan S; Muralidhar S; Huang GD; Ramoni R; Beltrao P; Danesh J; Hung AM; Chang KM; Sun YV; Joseph J; Leach AR; Edwards TL; Cho K; Gaziano JM; Butterworth AS; Casas JP;
    Nat Med; 2021 Apr; 27(4):668-676. PubMed ID: 33837377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for sarcopenia.
    Yin KF; Chen T; Gu XJ; Su WM; Jiang Z; Lu SJ; Cao B; Chi LY; Gao X; Chen YP
    J Cachexia Sarcopenia Muscle; 2024 Apr; ():. PubMed ID: 38644354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rho GTPase gene expression and breast cancer risk: a Mendelian randomization analysis.
    Kazmi N; Robinson T; Zheng J; Kar S; Martin RM; Ridley AJ
    Sci Rep; 2022 Jan; 12(1):1463. PubMed ID: 35087170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-omics Mendelian randomization integrating GWAS, eQTL, and mQTL data identified genes associated with breast cancer.
    Zhang Z; Fang T; Chen L; Ji F; Chen J
    Am J Cancer Res; 2024; 14(3):1433-1445. PubMed ID: 38590415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential drug targets for tumors identified through Mendelian randomization analysis.
    Song N; Shi P; Cui K; Zeng L; Wang Z; Di W; Li J; Fan Y; Li Z; Zhang J; Su W; Wang H
    Sci Rep; 2024 May; 14(1):11370. PubMed ID: 38762700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of lipid-lowering drugs with COVID-19 outcomes from a Mendelian randomization study.
    Huang W; Xiao J; Ji J; Chen L
    Elife; 2021 Dec; 10():. PubMed ID: 34866576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between circulating vitamin E and ten common cancers: evidence from large-scale Mendelian randomization analysis and a longitudinal cohort study.
    Xin J; Jiang X; Ben S; Yuan Q; Su L; Zhang Z; Christiani DC; Du M; Wang M
    BMC Med; 2022 May; 20(1):168. PubMed ID: 35538486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide Mendelian randomization identifies actionable novel drug targets for psychiatric disorders.
    Liu J; Cheng Y; Li M; Zhang Z; Li T; Luo XJ
    Neuropsychopharmacology; 2023 Jan; 48(2):270-280. PubMed ID: 36114287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Summary-data-based Mendelian randomization prioritizes potential druggable targets for multiple sclerosis.
    Jacobs BM; Taylor T; Awad A; Baker D; Giovanonni G; Noyce AJ; Dobson R
    Brain Commun; 2020; 2(2):fcaa119. PubMed ID: 33005893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unveiling potential drug targets for hyperparathyroidism through genetic insights via Mendelian randomization and colocalization analyses.
    Chen B; Wang L; Pu S; Guo L; Chai N; Sun X; Tang X; Ren Y; He J; Hao N
    Sci Rep; 2024 Mar; 14(1):6435. PubMed ID: 38499600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic targets for endometriosis: Genome-wide Mendelian randomization and colocalization analyses.
    Zeng P; Lu L; Zhang H; Li Y; Tan S; Yu T; Zhou H
    Gene; 2024 Jan; 893():147970. PubMed ID: 37931855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing antidiabetic drugs for rheumatoid arthritis: results from a two-sample Mendelian randomization study.
    Qin C; Diaz-Gallo LM; Tang B; Wang Y; Nguyen TD; Harder A; Lu Y; Padyukov L; Askling J; Hägg S
    Eur J Epidemiol; 2023 Jul; 38(7):809-819. PubMed ID: 37052755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.